| 1 | [rituximab] | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 11 11, 14 💬
|
| 2 | Abatacept, rituximab or tocilizumab | [3] Abatacept Abatacept, Rituximab (Rituximab), Tocilizumab | [3] Tocilizumab
Tocilizumab
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Abatacept
💬
| [4] CD80 CD80, CD86, IL6R, MS4A1 💬
| [25] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Coronavirus disease, Cytokine-cytokine receptor interaction, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 3 | ABP 798 - Biosimilar to rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 4 | ABP 798 Biosimilar to Rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 5 | Addition of rituximab if recurrence | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 11 11 💬
|
| 6 | Administration of rituximab and methylprednisolone | [2] Methylprednisolone Methylprednisolone, Rituximab (Rituximab) | [3] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 7 | Alemtuzumab and Rituximab | [2] Alemtuzumab Alemtuzumab, Rituximab (Rituximab) | [2] Alemtuzumab
Alemtuzumab
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 60 60 💬
|
| 8 | Alemtuzumab, Rituximab | [2] Alemtuzumab Alemtuzumab, Rituximab (Rituximab) | [2] Alemtuzumab
Alemtuzumab
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬
|
| 9 | Anti-CD20 therapies (Ocrelizumab, Rituximab, Ofatumumab) | [3] Ocrelizumab Ocrelizumab, Ofatumumab, Rituximab (Rituximab) | [3] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Ocrelizumab
,
Ofatumumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 10 | Belimumab in SLE patients / Rituximab in RA patients | [2] Belimumab Belimumab, Rituximab (Rituximab) | [2] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Belimumab
💬
| [2] MS4A1 MS4A1, TNFSF13B 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 46 46, 49 💬
|
| 11 | Bendamustine, Rituximab | [2] Bendamustine Bendamustine, Rituximab (Rituximab) | [4] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Bendamustine hydrochloride
,
Bendamustine
,
Bendamustine hydrochloride hydrate
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 61 61 💬
|
| 12 | Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine | [3] Azathioprine Azathioprine, Dexamethasone, Rituximab (Rituximab) | [6] Azathioprine
Azathioprine
,
Dexamethasone
,
Dexamethasone sodium phosphate
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Azathioprine sodium
,
Dexamethasone phosphate
💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 35 35 💬
|
| 13 | Combination of Rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬
|
| 14 | Combination of Rituximab with subcutaneous belimumab | [2] Belimumab Belimumab, Rituximab (Rituximab) | [2] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Belimumab
💬
| [2] MS4A1 MS4A1, TNFSF13B 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 63 63 💬
|
| 15 | Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 85 85 💬
|
| 16 | Cyclophosphamide/Rituximab | [2] Cyclophosphamide Cyclophosphamide, Rituximab (Rituximab) | [3] Cyclophosphamide
Cyclophosphamide
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Cyclophosphamide
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 17 | Dexamethasone and Rituximab | [2] Dexamethasone Dexamethasone, Rituximab (Rituximab) | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Dexamethasone phosphate
💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 18 | Diagnostic Test: Zirconium Zr 89 labelled rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 41 41 💬
|
| 19 | Double-Blind Rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 51 51 💬
|
| 20 | Dr. Reddy’s Rituximab (DRL_RI) 100mg | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 21 | Dr. Reddy’s Rituximab (DRL_RI) 500mg | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 22 | Eltrombopag combining rituximab | [2] Eltrombopag Eltrombopag, Rituximab (Rituximab) | [3] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Eltrombopag olamine
,
Eltrombopag choline
💬
| [2] MPL MPL, MS4A1 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 23 | Etanercepet, Rituximab, Abatacept, Tocilizumab, Sarilumab | [4] Abatacept Abatacept, Rituximab (Rituximab), Sarilumab, Tocilizumab | [4] Tocilizumab
Tocilizumab
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Abatacept
,
Sarilumab
💬
| [4] CD80 CD80, CD86, IL6R, MS4A1 💬
| [25] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Coronavirus disease, Cytokine-cytokine receptor interaction, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 24 | Experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 222 222 💬
|
| 25 | GP2013 - A Proposed biosimilar rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 26 | Higher Dose of Rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬
|
| 27 | IDEC-C2B8 (rituximab) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 28 | Immunosuppressive treatment (eg, rituximab) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 64 64 💬
|
| 29 | Individualized dose of rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 30 | Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab | [12] Acetate Acetate, Alemtuzumab, Cladribine, Dimethyl fumarate, Fingolimod, Glatiramer, Natalizumab, Ocrelizumab, Ofatumumab, Ponesimod, Rituximab (Rituximab), Teriflunomide | [13] Cladribine
Cladribine
,
Alemtuzumab
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Dimethyl fumarate
,
Fingolimod hydrochloride
,
Glatiramer acetate
,
Ocrelizumab
,
Natalizumab
,
Ofatumumab
,
Fingolimod
,
Teriflunomide
,
Ponesimod
,
Fingolimod lauryl sulfate
💬
| [26] DHODH DHODH, HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, ITGA4, KEAP1, MS4A1, RRM1, S1PR1 💬
| [58] Allograft rejection Allograft rejection, Antigen processing and presentation, Arrhythmogenic right ventricular cardiomyopathy, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Chemical carcinogenesis - reactive oxygen species, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Efferocytosis, Endocytosis, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Integrin signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Phagocytosis, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Ubiquitin mediated proteolysis, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | [1] 13 13 💬
|
| 31 | Intravenous Rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 66 66 💬
|
| 32 | Low-dose rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬
|
| 33 | MabionCD20 (candidate biosimilar to rituximab) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 34 | MabThera (Rituximab) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [4] 13 13, 46, 49, 53 💬
|
| 35 | Mabthera or biosimilar Rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 48 48, 61 💬
|
| 36 | Mabthera or biosimilar rituximab product | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 37 | MabThera® (rituximab) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 38 | Originator rituximab - Rituxan ® or MabThera ® | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 39 | Other: Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsq | [8] Alemtuzumab Alemtuzumab, Cladribine, Hyaluronidase, Natalizumab, Ocrelizumab, Ofatumumab, Rituximab (Rituximab), Ublituximab | [10] Cladribine
Cladribine
,
Alemtuzumab
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Hyaluronidase
,
Hyaluronidase
,
Ocrelizumab
,
Hyaluronidase
,
Natalizumab
,
Ofatumumab
,
Ublituximab
💬
| [3] ITGA4 ITGA4, MS4A1, RRM1 💬
| [21] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Focal adhesion, Glutathione metabolism, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 💬
|
| 40 | Perfusion of treatment Rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 41 | Prednisone, low dose rituximab | [2] Prednisone Prednisone, Rituximab (Rituximab) | [2] Prednisone
Prednisone
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 61 61 💬
|
| 42 | RhTPO in combination with Rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬
|
| 43 | Rituxan (INN: Rituximab), brand name in the United States | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 44 | Rituxan (INN: Rituximab), brand name in the US | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 45 | Rituxan (rituximab) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 46 | Rituxan® (rituximab) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 47 | RITUXIMAB | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [54] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 48 | Rituximab (active comparator) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 49 | Rituximab (anti-CD20) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 53 53 💬
|
| 50 | Rituximab (Arm A) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 43 43, 44 💬
|
| 51 | Rituximab (Arm B) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [3] 43 43, 44, 63 💬
|
| 52 | Rituximab (EU) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 53 | Rituximab (genetical recombination) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [3] 14 14, 222, 223 💬
|
| 54 | Rituximab (MABTHERA and BIOSIMILARS) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 35 35, 162 💬
|
| 55 | Rituximab (Mabthera ®) Belimumab (Benlysta ®) | [2] Belimumab Belimumab, Rituximab (Rituximab) | [2] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Belimumab
💬
| [2] MS4A1 MS4A1, TNFSF13B 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 63 63 💬
|
| 56 | Rituximab (Mabthera) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 14 14, 63 💬
|
| 57 | Rituximab (MABTHERA® or RITUXAN®). | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [3] 35 35, 61, 63 💬
|
| 58 | Rituximab (Mabthera®) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 61 61 💬
|
| 59 | Rituximab (R) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [3] 13 13, 43, 44 💬
|
| 60 | Rituximab (Rituxan) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 11 11 💬
|
| 61 | Rituximab (RTX) and Azathioprine (AZA) | [2] Azathioprine Azathioprine, Rituximab (Rituximab) | [3] Azathioprine
Azathioprine
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Azathioprine sodium
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 65 65 💬
|
| 62 | Rituximab (US) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 63 | Rituximab - MabThera | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 64 | Rituximab 1g IV | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 162 162 💬
|
| 65 | Rituximab 1g/6months | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 66 | Rituximab 200mg/6months | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 67 | Rituximab [MabThera/Rituxan] | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 46 46, 63 💬
|
| 68 | Rituximab [MabThera] | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 69 | Rituximab and Cyclophosphamide IV | [2] Cyclophosphamide Cyclophosphamide, Rituximab (Rituximab) | [3] Cyclophosphamide
Cyclophosphamide
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Cyclophosphamide
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 35 35 💬
|
| 70 | Rituximab and dexamethasone | [2] Dexamethasone Dexamethasone, Rituximab (Rituximab) | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Dexamethasone phosphate
💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 71 | Rituximab and Hyaluronidase Human | [2] Hyaluronidase Hyaluronidase, Rituximab (Rituximab) | [4] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 331 331 💬
|
| 72 | Rituximab Biosimilar | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 222 222 💬
|
| 73 | Rituximab Biosimilar ABP 798 | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 222 222 💬
|
| 74 | Rituximab combined with corticosteroids | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 222 222 💬
|
| 75 | Rituximab combined with Daratumumab(Anti-CD38 Monoclonal Antibody) | [2] Daratumumab Daratumumab, Rituximab (Rituximab) | [2] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Daratumumab
💬
| [2] CD38 CD38, MS4A1 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 63 63 💬
|
| 76 | Rituximab combined with Omalizumab | [2] Omalizumab Omalizumab, Rituximab (Rituximab) | [2] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Omalizumab
💬
| [2] FCER1A FCER1A, MS4A1 💬
| [5] Asthma Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | [1] 162 162 💬
|
| 77 | Rituximab combined with tacrolimus induction + rituximab maintenance | [2] Rituximab Rituximab (Rituximab), Tacrolimus | [3] Tacrolimus
Tacrolimus
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Tacrolimus
💬
| [6] MS4A1 MS4A1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [34] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 78 | Rituximab combined with tacrolimus induction + tacrolimus maintenance | [2] Rituximab Rituximab (Rituximab), Tacrolimus | [3] Tacrolimus
Tacrolimus
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Tacrolimus
💬
| [6] MS4A1 MS4A1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [34] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 79 | Rituximab Infusion | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [3] 13 13, 222, 223 💬
|
| 80 | Rituximab Injection | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [3] 11 11, 35, 222 💬
|
| 81 | Rituximab IT | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 82 | Rituximab IV | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 83 | Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 84 | Rituximab MabThera | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 85 | Rituximab plus methylprednisolone | [2] Methylprednisolone Methylprednisolone, Rituximab (Rituximab) | [3] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 86 | Rituximab(RTX) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 87 | Rituximab, Cyclophosphamide, and Corticosteroids | [2] Cyclophosphamide Cyclophosphamide, Rituximab (Rituximab) | [3] Cyclophosphamide
Cyclophosphamide
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Cyclophosphamide
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 222 222 💬
|
| 88 | Rituximab, Mabthera | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 53 53 💬
|
| 89 | Rituximab, MTX, folic acid | [2] Folic acid Folic acid, Rituximab (Rituximab) | [3] Folic acid
Folic acid
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Folate sodium
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 90 | Rituximab, observational study amon patients with active RA | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 91 | Rituximab-EU+ Rituximab-Pfizer x 2 Courses | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 92 | Rituximab-Pfizer | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 93 | Rituximab-Pfizer (PF-05280586) x 3 courses | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 94 | Rituximab-US + Rituximab-Pfizer x 2 Courses | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 95 | Rituximab/ Mabthera | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 271 271 💬
|
| 96 | SAIT101 (proposed rituximab biosimilar) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 97 | SAIT101 (rituximab biosimilar) | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 98 | Sequential treatment with rituximab and cladribine | [2] Cladribine Cladribine, Rituximab (Rituximab) | [2] Cladribine
Cladribine
,
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [2] MS4A1 MS4A1, RRM1 💬
| [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Hematopoietic cell lineage, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬
|
| 99 | Single infusion of Rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 222 222 💬
|
| 100 | Standard dose of rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 101 | The Standard Steroid Treatment, Plasma Exchange and rituximab | [1] Rituximab Rituximab (Rituximab) | [1] Rituximab
Rituximab
(Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 85 85 💬
|